000 | 01977 a2200553 4500 | ||
---|---|---|---|
005 | 20250515014141.0 | ||
264 | 0 | _c20070119 | |
008 | 200701s 0 0 eng d | ||
022 | _a1053-8569 | ||
024 | 7 |
_a10.1002/pds.1214 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeeger, John D | |
245 | 0 | 0 |
_aAchilles tendon rupture and its association with fluoroquinolone antibiotics and other potential risk factors in a managed care population. _h[electronic resource] |
260 |
_bPharmacoepidemiology and drug safety _cNov 2006 |
||
300 |
_a784-92 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAchilles Tendon _xinjuries |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAdverse Drug Reaction Reporting Systems |
650 | 0 | 4 | _aAge Distribution |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadverse effects |
650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFluoroquinolones _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aManaged Care Programs _xstatistics & numerical data |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aObesity _xcomplications |
650 | 0 | 4 | _aPopulation Surveillance |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aRupture |
650 | 0 | 4 | _aSex Distribution |
650 | 0 | 4 |
_aSkin Diseases, Infectious _xcomplications |
650 | 0 | 4 |
_aSoft Tissue Infections _xcomplications |
650 | 0 | 4 |
_aTendon Injuries _xchemically induced |
650 | 0 | 4 |
_aUnited States _xepidemiology |
700 | 1 | _aWest, William A | |
700 | 1 | _aFife, Daniel | |
700 | 1 | _aNoel, Gary J | |
700 | 1 | _aJohnson, Larry N | |
700 | 1 | _aWalker, Alexander M | |
773 | 0 |
_tPharmacoepidemiology and drug safety _gvol. 15 _gno. 11 _gp. 784-92 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/pds.1214 _zAvailable from publisher's website |
999 |
_c16070183 _d16070183 |